AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 102 filers reported holding AEGERION PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $147,000 | -34.7% | 7,753 | -9.7% | 0.00% | – |
| Q1 2015 | $225,000 | -91.2% | 8,584 | -88.8% | 0.00% | -100.0% |
| Q3 2014 | $2,569,000 | -29.4% | 76,949 | -32.1% | 0.00% | -25.0% |
| Q2 2014 | $3,637,000 | -18.4% | 113,322 | +17.4% | 0.00% | -33.3% |
| Q1 2014 | $4,459,000 | -18.8% | 96,554 | +24.7% | 0.01% | -14.3% |
| Q4 2013 | $5,493,000 | +33.4% | 77,418 | +61.3% | 0.01% | +16.7% |
| Q3 2013 | $4,117,000 | +166.3% | 48,011 | +96.7% | 0.01% | +200.0% |
| Q2 2013 | $1,546,000 | – | 24,412 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT INTERNATIONAL, L.P. | 447,001 | $14,344,000 | 100.00% |
| Broadfin Capital, LLC | 1,620,088 | $51,988,000 | 2.56% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,899,585 | $93,048,000 | 2.40% |
| Tamarack Capital Management, LLC | 400,000 | $11,656,000 | 2.38% |
| March Altus Capital Management LP | 199,037 | $6,387,000 | 2.34% |
| PRICE MICHAEL F | 240,000 | $7,702,000 | 0.94% |
| DELTEC ASSET MANAGEMENT LLC | 106,151 | $3,406,000 | 0.72% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3,207,598 | $102,932,000 | 0.61% |
| CLOUGH CAPITAL PARTNERS L P | 508,800 | $16,327,000 | 0.52% |
| Catalyst Capital Advisors LLC | 86,500 | $2,776,000 | 0.45% |